spin

About Abstract submission

SLENDO 2023 encourages you to showcase your work in this unique forum. We welcome scientific work in the field of diabetes, and endocrinology that is innovative. Case reports or case series that describe a particular clinical problem and challenge the current treatment paradigm are also welcome. We welcome you to grab this opportunity to shape our scientific program and help ensure that the most relevant spectrum of topics is presented at the meeting.

SLENDO 2023 will provide a valuable opportunity for allied health professionals to showcase their scientific studies in the form of either research or case studies, which in turn will serve as a platform to interact and expand the horizons of knowledge in the field of Endocrinology. We are excited by the initiative and look forward to your submissions and hope, that delegates will make the best out of this golden opportunity.

All are invited to submit scientific abstracts of original research/case reports in the field of diabetes or endocrinology. Please note that abstracts that are not prepared according to the guidelines provided, or are submitted after the deadline, will not be considered for review. The SLENDO scientific committee reserves the right to reject the abstracts and to make alterations to the text of the abstract which will improve its quality.

The deadline to submit abstracts is 30th April 2023   22nd May 2023 23:59 India Standard Time (IST).

Abstract Submission – SLENDO 2023

Abstract Categories

  • Diabetes
  • Endocrinology

General Instructions for Submission 

  • All abstracts should be submitted online through the abstract submission web portal. (https://abstract.slendo.lk)
  • Please note that there is no facility to submit hard copies directly to the SLENDO office, please do not send abstracts via email.
  • The language of the entries should be set to English (UK).
  • All abstracts should be uploaded to SLENDO online portal on or before  30th April 2023 22th May 2023. Late entries will not be accepted.
  • The author/s should take full public responsibility for the research work/case reports and the contents reported in the abstract.
  • By submitting the abstract, you agree to present the abstract if selected for presentations (poster/oral) at the SLENDO 2023– Colombo, Sri Lanka.

Abstract submission guidelines

  • The abstract must report original research, case reports, systematic reviews or metanalyses, not previously published elsewhere.
  • The abstracts should be in English, coherent and free of language errors. No translation service will be available.
  •  The title should be brief and in capitals and reflect the study reported.
  • The name with initials and designations of all authors and the place (or places) where the research work was conducted should be stated. The name of the author who will present the paper should be underlined. Do not use prefixes such as Dr., Prof., Mr., Ms., etc. Do not include qualifications here.
  • The text of the abstract should not exceed 300 words excluding the title, author affiliations, acknowledgements, keywords and references.
  • The body of the text should be typed in Times New Roman (font size 12). Use Arabic numerals and SI units throughout. The abstract should describe the original work and indicate the purpose of the study, methods and materials used, statistical methods employed and results obtained. Case reports should include an introduction, case report, discussion and conclusions. Statements such as “conclusions will be discussed at the session” are unacceptable.
  •  A maximum of five keywords should be provided.
  • All authors should give written consent for the abstract.
  • Acknowledgements should be restricted to the names of funding agencies providing sponsorship.
  • During submission, in addition to entering your abstract in the given template, a PDF version of your abstract should be attached (should not contain author details), along with the duly signed consent form.

 

Please note:

  • All correspondence will be addressed to the corresponding author.
  • In the event that the presenter indicated in the application is unable to present the paper, it is the responsibility of the corresponding author either to withdraw the paper in advance or arrange for one of the co-authors to present the paper. In the event that the abstract is not presented, the abstract will be withdrawn from the final abstract book, and all co-authors will be notified.
  • Ethical considerations – where applicable, the Ethics Review Committee approval should be mentioned. For clinical trials, the clinical trials registry number should be submitted.
  • The SLENDO scientific committee shall have full authority to accept or reject a paper upon evaluation of the title and the abstract. The rejection of a paper by the selection committee is final.
  • Abstract submissions accepted by the Scientific Committee will be published in the conference proceedings only if the presenting author is registered and paid in full by the 30th of June 2023.

 

SLENDO 2023 reserves the right to make alterations and edit the contents of the abstract to improve the quality of the presentation.

Format of an abstract

Research Category

The title of the abstract: Should be brief but adequately descriptive.

Introduction: One or two sentences indicating the gravity of the problem.

Objectives: The main objective/s of the study.

Methods: Give sufficient details of the study setting, subjects, selection process, measurements and analyses. Indicate the statistics used to analyze data. (Need not indicate the software used for statistical analyses.)

Results: Sufficient data to address objectives and support conclusions.

Conclusions: Should be based on the results and observations of the study. References and acknowledgements are not required. However, these can be included in the presentation.

Word Limit: 300 words only

Case Report Category

The title of the abstract: Should be brief but adequately descriptive.

Introduction: Briefly describe the background for the case, explain why this case is noteworthy and what it adds to current knowledge.

 Case Description: Relevant information may include basic demographics, the patient’s main symptoms or other reasons for seeking care, clinical assessment, treatment plan, and health outcomes. Given the space limitations, include only the information relevant.

Conclusion: This section should emphasize the learning point(s) and implications for clinical practice highlighted in the case.

Word Limit: 300 words only

Informing the authors

  • Abstracts not conforming to the above instructions will be rejected
  • The SLCE reserves the right to decide the mode of the presentation at SLENDO 2023 (Oral/Poster).
  • Please note that NO amendments to the submitted abstracts (including the number of authors) would be entertained thereafter.